Advertisements
Feeds:
Posts
Comments

Archive for the ‘Interviews with Scientific Leaders’ Category


Gerald D Aurbach Award for Outstanding Translational Research

 

Reporter and Curator: Aviva Lev-Ari, PhD, RN

 

Supported by the Gerald D. Aurbach Memorial Fund — Gerald D Aurbach Award for Outstanding Translational Research in the name of Gerald D. Aurbach, MD, the Endocrine Society’s 68th president, was a renowned researcher, mentor, and clinician, and his work revolutionized the understanding of bone metabolism and calcium homeostasis.

 

Past Award Recipients
Select Year
2017
2016
2015
By year:

Eligibility Criteria for Gerald D Aurbach Award for Outstanding Translational Research

  • This award is not limited to members of the Endocrine Society

Application Process

Updates to existing nominations must be emailed to laureate@endocrine.org.

New nominations must be submitted by the primary nominator who is responsible for collecting and merging supporting documents in a single document (PDF or Word) in the order listed below:

  1. 300-word citation (will be published as-is in Endocrine News if the nominee is selected)
  2. Letter of Support (1 page each, no more than 2)
  3. List of 10 Most Significant Publications
  4. CV (abbreviated versions will not be accepted)

SOURCE

https://www.endocrine.org/awards/laureate-awards/gerald-d-aurbach-award-for-outstanding-translational-research

Advertisements

Read Full Post »


Recognitions for Contributions in Genomics by Dan David Prize Awards

Reporter: Aviva Lev-Ari, PhD, RN

 

The Source for this List is a Search for “Genomics” on the Dan David Prize website

http://www.dandavidprize.org/component/finder/search?q=Genomics&Itemid=101

This is a compilation of all Dan David Prizes awarded in the Field of Genomics

When Will Genomics Cure Cancer?
A conversation with the biogeneticist ERIC S. LANDER [2012 laureate] about how genetic advances are transforming medical treatment “Eric S. Lander, one of the leaders of the Human Genome Project, a map of the 3 billion letters of DNA that make up a…

J. Craig Venter
Founder, Chairman, and President of the J. Craig Venter Institute, Rockville, MD and La Jolla, CA, USA and CEO of Synthetic Genomics Inc., La Jolla, CA, USA.

David Botstein
Anthony B. Evnin Professor of Genomics; Director, Lewis-Sigler Institute for Integrative Genomics; Director, Certificate Program in Quantitative and Computational Biology, Princeton University, Princeton, NJ, USA.

Laureates Announced 2012
Dan David Prize 2012 Laureates Announced Robert Conquest, Martin Gilbert – for Biography/History William Kentridge – for Plastic Arts David Botstein, Craig Venter, Eric Lander – for Genome Research Tel Aviv (February 27, 2012) —The international Dan…

Cutting Edge Genomic Research in the World’s First Carbon-Neutral Laboratory Facility
J. CRAIG VENTER, 2012 laureate, is Founder, Chairman, and President of the J. Craig Venter Institute, Rockville, MD and La Jolla, CA, USA and CEO of Synthetic Genomics Inc., La Jolla, CA, USA. “One of our quests is to help solve two troubling issues —…

Prof. David Haussler
Prof. David Haussler is a Distinguished Professor of Biomolecular Engineering at the University of California, Santa Cruz, and Scientific Director of the UC Santa Cruz Genomics Institute.

Eric Lander
Founding Director, Broad Institute Harvard and MIT and director of its Genome Biology Program, Cambridge, MA, USA.

Future – Bioinformatics
Bioinformatics is a field in which mathematics, statistics, and computer algorithms are harnessed towards novel biological discoveries. Bioinformatics methodologies have revolutionized biology, by making it more quantitative and less descriptive….

J. CRAIG VENTER – Life at the Speed of Light
The Dawn of an Era In his NEW BOOK ‘Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life’ J. CRAIG VENTER, 2012 laureate, explains the coming era of discovery (see Wired interview below). What is the significance of Venter’s…

From the Press : Hebrew
The Marker, June 14, 2012 – Dan David Prize: The Next Generation Calcalist, June 14, 2012 – Dan David Prize Awarded: Thoughts of Creating Life, Boycotting Scientists, Protests, Entrepreneurs and Ceremonies Ma’ariv, June 12, 2012 – Who Attended the Dan…

Gary Ruvkun
Professor of Genetics, Department of Molecular BiologyMassachusetts General Hospital, Harvard University Gary Ruvkun has made a major contribution to the future of human health with the discovery of conserved hormonal signaling pathways with…

Selected Fields 2012
Past – HISTORY / BIOGRAPHY Biography is an important sub-discipline of history. Every progressive society makes room for achievement and excellence. Since ancient times, this has been done by immortalizing the names of heroes, role models and…

Prof. Michael S. Waterman
Prof. Michael S. Waterman is Professor of Biological Sciences, of Mathematics, of Computer Science, Department of Biological Sciences, University of Southern California.

 SOURCE
Other related articles published in this Open Access Online Scientific Journal include the following:

2013 Genomics: The Era Beyond the Sequencing of the Human Genome: Francis Collins, Craig Venter, Eric Lander, et al.

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2013/02/11/2013-genomics-the-era-beyond-the-sequencing-human-genome-francis-collins-craig-venter-eric-lander-et-al/

Read Full Post »


2017 Honorary Doctorate Ceremony at Technion – Israel Institute of Technology included MIT President, Prof. Rafael Reif

Reporter: Aviva Lev-Ari, PhD, RN

 

 

MIT President at Technion – Honorary Doctorate Ceremony

MIT President at Technion: Universities Play a Major Role in Making a Better World

Prof. Rafael Reif spoke at Technion’s Honorary Doctorate Conferment Ceremony

“In the United States and in many nations around the world, now is a moment of change. As we navigate uncertainty around the globe, it is useful to remind ourselves and the world that universities can be a powerful, steady force for good. In fact, I believe that this moment offers a remarkable opportunity for research universities to be leaders: leaders in education, leaders in research, and in particular, leaders in solving problems, to make a better world.”

The remarks were made on Monday by MIT President Prof. Rafael Reif, at Technion’s Honorary Doctorate Conferment Ceremony.

Technion President Prof. Peretz Lavie spoke at the ceremony about the rapidly changing world and  academia’s duty to adapt itself to these changes. “Among other things, we must provide our students with the tools they will need in the changing labor market, adopt the appropriate learning methodologies for the new world, expand a frameworks to encourage interdisciplinary research, and strengthen the triangular relationship between academia, government, and industry. Thanks to leaders like you, honorary doctorate recipients, I have no doubt that we will be able to successfully deal with the fourth industrial revolution which we are in the midst of.”

SOURCE

http://www.technion.ac.il/en/2017/06/mit-president-at-technion-honorary-doctorate-ceremony/

Read Full Post »


Two Connectionists and Two Conversationalists – Brain Science is the Expertise of First-term incoming President of Hebrew University of Jerusalem and Third-term President of Technion, Israel Institute of Technology

Reporter: Aviva Lev- Ari, PhD, RN

 

Two Connectionists and Two Conversationalists

 

Professor Asher Cohen, was elected President of the Hebrew University of Jerusalem

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2017/05/17/professor-asher-cohen-was-elected-president-of-the-hebrew-university-of-jerusalem/

 

Prof. Peretz Lavie – CV

Prof. Peretz Lavie is the 16th president of Technion – Israel Institute of Technology, having taken the position on October 1, 2009.  Between 1993 and 1999, Prof. Lavie served as dean of the Rappaport Faculty of Medicine, and between 2001 and 2008, as Technion’s vice president for resource development and external relations.

Prof. Lavie is a world-respected Lavie authority on the psychophysiology of sleep and sleep disorders. He is the author of several books, including: The Enchanted World of Sleep; and Restless Nights: Understanding Sleep Apnea and Snoring. He has founded several start-up companies, including Itamar Medical Ltd.

http://pard.technion.ac.il/technion-president/

 

President Prof. Peretz Lavie Elected to 3rd Term

 

During Prof. Lavie’s current term in office (2009-2017), Technion recorded impressive achievements led by the recruitment of more than 200 new faculty members. “Outstanding faculty members are the most important asset of any university,” said Prof. Lavie. “The quality of Technion and its future status will be determined first and foremost by the quality of its faculty members.”

The new faculty members, whose recruitment involved the extensive recruitment of resources, are mostly young and were selected based on excellence in research. The increase in the number of faculty members was accompanied by a significant increase in the number of publications in the world’s leading scientific journals. In 2016, Technion was ranked 26th in the world in the list of Rising Stars, published by the leading scientific journal Nature, following a 40% increase in Technion’s publications in leading scientific journals. In the Shanghai ranking, the world’s leading index of academic institutions, within eight years Technion shot up from rank 101-152 worldwide to 69th place in 2016: the top of Israel’s universities. These rankings, along with a significant increase in the awarding of research grants, attest to Technion’s academic excellence and the research achievements of its faculty members.

The Jacobs Technion-Cornell Institute – photo simulation – Credit: Morphosis [Thom Mayne]

The research world, in Prof. Lavie’s view, is changing. In the past, a scientist could carry out research and achieve breakthroughs on his own, but now significant research requires interdisciplinary cooperation. “The walls between disciplines, faculties, and fields of research are collapsing,” explains Prof. Lavie. “Future achievements in science and engineering will require cooperation between laboratories and researchers from different fields. In order to achieve significant scientific and engineering breakthroughs, enormous knowledge is now required — knowledge that an individual scientist does not possess.” For this reason, Technion has worked to establish interdisciplinary centers where researchers from different faculties work together. These centers include research institutes such as the Technion Integrated Cancer Center (TICC), the Quantum Engineering Center, the Cyber Security Research Center, and the Technion Computer Engineering Center (TCE), in addition to the Excellence Centers of the Council for Higher Education that have been established at Technion.

The number of students at Technion is growing steadily. In the past eight years, the number of students has increased from 12,665 (2009-2010) to 14,121 (2016-2017). In addition, there has been a 30% increase in the number of graduate students (master’s and doctoral).

Since taking office as President, Prof. Lavie has worked to change the atmosphere at Technion and its image as a rigid institution that is not sufficiently considerate of its students. Under his leadership, a committee was established to examine the structure of studies and academic load at Technion, headed by Prof. Yachin Cohen of the Faculty of Chemical Engineering. The committee’s recommendations, which were implemented in conjunction with the Technion Student Association (TSA), included many changes aimed at improving teaching at Technion.

In addition, in 2012 Prof. Lavie instituted the Yanai Prize for Excellence in Academic Education, with the generous donation of Technion alumnus Moshe Yanai. The prize, which is awarded in recognition and appreciation of faculty members who set an example by their contributions to teaching and learning, has already become synonymous with excellence in teaching at Technion and has been awarded to 62 faculty members and three faculties.

http://www.technion.ac.il/en/2017/05/president-prof-peretz-lavie-elected-to-3rd-term/

Read Full Post »


Professor Asher Cohen, was elected President of the Hebrew University of Jerusalem

Reporter: Aviva Lev-Ari, PhD, RN

Professor Asher Cohen CV

https://scholars.huji.ac.il/jbc/people/prof-asher-cohen-0

 

  • Hebrew University Search Committee Recommends Rector Asher Cohen for President

    May 17, 2017 — Following a rigorous search process, the presidential search committee has unanimously recommended that the university’s Rector, Professor Asher Cohen, be elected President of the Hebrew University of Jerusalem. The recommendation will be brought for approval to the Board of Managers and the Executive Committee.

    As Rector of the Hebrew University for the past five years, Professor Cohen led a number of important processes. These include recruiting top researchers from Israel and around the world and providing them with the tools to stand at the forefront of global research, refreshing the university’s curricula and developing innovative programs that combine diverse disciplines, and increasing the university’s international cooperation and student and staff exchanges with leading institutions around the world.

    After graduating with a B.A. in Economics and an M.A. in Psychology from the Hebrew University, Professor Cohen did his doctoral and post-doctoral studies at the University of Oregon in the United States. He served as a senior lecturer at Indiana University before returning in the early 1990s to the Hebrew University’s Department of Psychology, in the Faculty of Social Sciences. From 2008 to 2012, he served as the head of the Department of Psychology. He also held various leadership positions at the University, including being elected by his peers to serve as head of the Association of University Professors.

    Professor Cohen’s research in the cognitive sciences focuses on the relationship between the human perception system and human response mechanisms, in situations that require very fast motor responses. In the framework of his research, Professor Cohen developed a theoretical model that successfully predicts in which situations performing two tasks will lead to a decline in abilities.

    SOURCE

https://www.afhu.org/hebrew-university-search-committee-recommends-rector-asher-cohen-for-president/about/?utm_source=Master+List&utm_campaign=e15c035df9-EMAIL_CAMPAIGN_2017_05_17&utm_medium=email&utm_term=0_343e19a421-e15c035df9-92801633#.WRyIzRPyu9Z

Read Full Post »


Less is More: Minimalist Mitral Valve Repair: Expert Opinion of Prem S. Shekar, MD, Chief, Division of Cardiac Surgery, BWH – #7, 2017 Disruptive Dozen at #WMIF17

Reporter: Aviva Lev-Ari, PhD, RN

 

Highlights LIVE Day 3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017  BOSTON, MA • UNITED STATES

11:45 am – 12:45 pm
Boston Scientific Ballroom
Disruptive Dozen: 12 Technologies that will reinvent Cardiovascular Care
  • Chief of Cardiovascular Medicine, Brigham and Women’s Hospital
  • Associate Professor of Medicine, Harvard Medical School
  • Chief, Cardiology Division, Massachusetts General Hospital
  • Professor of Medicine, Harvard Medical School

12. Aging and Heart Disease: Can we reverse the process?

11.Nanotechnologies for Cardiac Diagnosis and Treatment

10. Breaking the Code: Diagnosis and Therapeutic Potential of RNA

9. Expanding the Pool of Organs for Transplant

8. Finding Cancer therapies without Cardiotoxicity

7. Less is more: Minimalist Mitral Valve Repair

6. Understanding Why exercise works for Just about every thing

5. Power Play: The Future of Implantable Cardiac Devices

4. Adopting the Orphan of Heart Disease

3. Targeting Inflammation in cardiovascular Disease

2. Harnessing Big Data and Deep Learning for Clinical Decision Support

  1. Quantitative Molecular Imaging for Cardiovascular Phynotypes

SOURCE

https://pharmaceuticalintelligence.com/2017/05/03/highlights-live-day-3-world-medical-innovation-forum-cardiovascular-%E2%80%A2-may-1-3-2017-boston-ma-%E2%80%A2-united-states/

 

Excerpts from Prem S. Shekar, MD Presentation

The success achieved with TAVR

  1. least traumatic
  2. short recovery
  3. quicker return to normal lifestyle

encouraged Medical devices Manufacturers to develop Mitral Valve Repair technologies to address the large unmet need for percutaneous treatment of patients with Mitral Valve disease:

Mild or Severe (4 Million in the US, alone).

  • Mitral Regurgitation (MR) – imperfect closure of the valve permits blood from LV to return back towards the lungs.

Causes for MR

  1. the degenerative myxomatous disease
  2. senile calcific degenerative disease causing enlargement of the LV, infection or Trauma.
  • Mitral stenosis – narrowing of the valve

Causes for Mitral Stenosis

  1. rheumatic fever
  2. senile calcific degeneration – obstruction to the forward flow of blood resulting in increased fluid pressure inside the lungs.

Symptoms of MR – managed by drugs or Surgery for correction (Open Heart surgery or MIS – both procedures require use of bypass machine, the heart been stopped for the duration of repair/replacement) for Valve Repair or Valve Replacement

  1. shortness of breath
  2. fatigue

Uncorrected Mitral Valve disease can lead to 

  1. irregular heart rhythms
  2. increased risk for stroke
  3. CHF
  4. Death

Transcatheter Mitral Valve Correction

  1. Valve replacement
  2. use of Repair devices on the Mitral leaflets
  3. implantation of neochords
  4. remodeling of the mitral annulus

Comparison of TARV with Transcatheter Mitral Valve Correction

  1. Aortic Valve vs Mitral Valve: difference in complexity and artistic nature of Mitral repair
  2. Ability to perform a Percutaneous repair on a Mitral Valve with same degree of accuracy and reproducibility as a Percutaneous repair on an Aortic Valve — will remain a challenge.
  3. development of advance imaging technologies will play a key role in achieveing success with Percutaneous repair on a Mitral Valve
  4. Percutaneous repair on a Mitral Valve need to overcome the complex structure and integrated relationship with the LV.

Leading Challenges in the Development of Percutaneous repair on a Mitral Valve Technologies

  1. Mitral is a bigger Valve than the Aortic
  2. It is more difficult to access
  3. It is Asymmetrical
  4. It lacks an anatomically well-defined annulus to which to anchor the artificial valve
  5. Its geometry changes throughout the cardiac cycle
  6. Placement of a replacement valve bears the risk of LV outflow tract obstruction

Patient Candidate Profile forPercutaneous repair on a Mitral Valve

  1. Patient with a failed Mitral Valve bioprosthesis – Severe Mitral Valve Disease
  2. Failed Mitral Valve Repairs
  3. Senile calcific degeneration
  4. Mitral Regurgitation unmanaged by medication
  5. Variable surgical risk related to co-morbidities

 

Other related articles on Mirtal Valve Disease covered in this Open Access Online Scientific Journal Include the following:

Search Category:

Cardiovascular Medical Devices: Cardiac Surgery, Cardiothoracic Surgical Procedures and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty – 248 articles

Mitral Valve Repair: Who is a Patient Candidate for a Non-Ablative Fully Non-Invasive Procedure? – Last Updated on 4/8/2017

Justin Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

 

Lev-Ari, A. 5/19/2014. Transcatheter Mitral Valve (TMV) Procedures: Centers for Medicare & Medicaid Services (CMS) proposes to cover Transcatheter Mitral Valve Repair (TMVR)

https://pharmaceuticalintelligence.com/2014/05/19/transcatheter-mitral-valve-tmv-procedures-centers-for-medicare-medicaid-services-cms-proposes-to-cover-transcatheter-mitral-valve-repair-tmvr/

 

Lev-Ari, A. 1/26/2014. Transcatheter Valve Competition in the United States: Medtronic CoreValve infringes on Edwards Lifesciences Corp. Transcatheter Device Patents

https://pharmaceuticalintelligence.com/2014/01/26/transcatheter-valve-competition-in-the-united-states-medtronic-corevalve-infringes-on-edwards-lifesciences-corp-transcatheter-device-patents/

 

Lev-Ari, A. 1/26/2014. Developments on the Frontier of Transcatheter Aortic Valve Replacement (TAVR) Devices

https://pharmaceuticalintelligence.com/2014/01/26/developments-on-the-frontier-of-transcatheter-aortic-valve-replacement-tavr-devices/

 

Larry H. Bernstein and
Aviva Lev-Ari 6/23/2013 Survivals Comparison of Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty

https://pharmaceuticalintelligence.com/2013/06/23/comparison-of-cardiothoracic-bypass-and-percutaneous-interventional-catheterization-survivals/

 

Larry H Bernstein and Lev-Ari, A. 6/23/2013 First case in the US: Valve-in-Valve (Aortic and Mitral) Replacements with Transapical Transcatheter Implants – The Use of Transfemoral Devices.

https://pharmaceuticalintelligence.com/2013/06/23/valve-in-valve-replacements-with-transapical-transcatheter-implants/

Larry H Bernstein and  Lev-Ari, A. 6/17/2013 Transcatheter Aortic Valve Replacement (TAVR): Postdilatation to Reduce Paravalvular Regurgitation During TAVR with a Balloon-expandable Valve

https://pharmaceuticalintelligence.com/2013/06/17/postdilatation-to-reduce-paravalvular-regurgitation-during-transcatheter-aortic-valve-replacement/

Larry H Bernstein and Lev-Ari, A. 6/17/2013 Trans-apical Transcatheter Aortic Valve Replacement in a Patient with Severe and Complex Left Main Coronary Artery Disease (LMCAD)

https://pharmaceuticalintelligence.com/2013/06/17/management-of-difficult-trans-apical-transcatheter-aortic-valve-replacement-in-a-patient-with-severe-and-complex-arterial-disease/

Larry H Bernstein and Lev-Ari, A. 6/18/2013 Ventricular Assist Device (VAD): A Recommended Approach to the Treatment of Intractable Cardiogenic Shock

https://pharmaceuticalintelligence.com/2013/06/18/a-recommended-approach-to-the-treatmnt-of-intractable-cardiogenic-shock/

Larry H Bernstein and Lev-Ari, A.6/20/2013 Phrenic Nerve Stimulation in Patients with Cheyne-Stokes Respiration and Congestive Heart Failure

https://pharmaceuticalintelligence.com/2013/06/20/phrenic-nerve-stimulation-in-patients-with-cheyne-stokes-respiration-and-congestive-heart-failure/

Lev-Ari, A. 2/12/2013 Clinical Trials on transcatheter aortic valve replacement (TAVR) to be conducted by American College of Cardiology and the Society of Thoracic Surgeons

https://pharmaceuticalintelligence.com/2013/02/12/american-college-of-cardiologys-and-the-society-of-thoracic-surgeons-entrance-into-clinical-trials-is-noteworthy-read-more-two-medical-societies-jump-into-clinical-trial-effort-for-tavr-tech-f/

Lev-Ari, A. 12/31/2012 Renal Sympathetic Denervation: Updates on the State of Medicine

https://pharmaceuticalintelligence.com/2012/12/31/renal-sympathetic-denervation-updates-on-the-state-of-medicine/

Lev-Ari, A. 9/2/2012 Imbalance of Autonomic Tone: The Promise of Intravascular Stimulation of Autonomics

https://pharmaceuticalintelligence.com/2012/09/02/imbalance-of-autonomic-tone-the-promise-of-intravascular-stimulation-of-autonomics/

Lev-Ari, A. 8/13/2012Coronary Artery Disease – Medical Devices Solutions: From First-In-Man Stent Implantation, via Medical Ethical Dilemmas to Drug Eluting Stentshttps://pharmaceuticalintelligence.com/2012/08/13/coronary-artery-disease-medical-devices-solutions-from-first-in-man-stent-implantation-via-medical-ethical-dilemmas-to-drug-eluting-stents/

Lev-Ari, A. 7/18/2012Percutaneous Endocardial Ablation of Scar-Related Ventricular Tachycardia

https://pharmaceuticalintelligence.com/2012/07/18/percutaneous-endocardial-ablation-of-scar-related-ventricular-tachycardia/

Lev-Ari, A. 6/13/2012Treatment of Refractory Hypertension via Percutaneous Renal Denervation

https://pharmaceuticalintelligence.com/2012/06/13/treatment-of-refractory-hypertension-via-percutaneous-renal-denervation/

Lev-Ari, A. 6/22/2012Competition in the Ecosystem of Medical Devices in Cardiac and Vascular Repair: Heart Valves, Stents, Catheterization Tools and Kits for Open Heart and Minimally Invasive Surgery (MIS)

https://pharmaceuticalintelligence.com/2012/06/22/competition-in-the-ecosystem-of-medical-devices-in-cardiac-and-vascular-repair-heart-valves-stents-catheterization-tools-and-kits-for-open-heart-and-minimally-invasive-surgery-mis/

Lev-Ari, A. 6/19/2012Executive Compensation and Comparator Group Definition in the Cardiac and Vascular Medical Devices Sector: A Bright Future for Edwards Lifesciences Corporation in the Transcatheter Heart Valve Replacement Market

https://pharmaceuticalintelligence.com/2012/06/19/executive-compensation-and-comparator-group-definition-in-the-cardiac-and-vascular-medical-devices-sector-a-bright-future-for-edwards-lifesciences-corporation-in-the-transcatheter-heart-valve-replace/

Lev-Ari, A. 6/22/2012Global Supplier Strategy for Market Penetration & Partnership Options (Niche Suppliers vs. National Leaders)in the Massachusetts Cardiology & Vascular Surgery Tools and Devices Market for Cardiac Operating Rooms and Angioplasty Suites

https://pharmaceuticalintelligence.com/2012/06/22/global-supplier-strategy-for-market-penetration-partnership-options-niche-suppliers-vs-national-leaders-in-the-massachusetts-cardiology-vascular-surgery-tools-and-devices-market-for-car/

Lev-Ari, A. 7/23/2012Heart Remodeling by Design: Implantable Synchronized Cardiac Assist Device: Abiomed’s Symphony

https://pharmaceuticalintelligence.com/2012/07/23/heart-remodeling-by-design-implantable-synchronized-cardiac-assist-device-abiomeds-symphony/

Lev-Ari, A. (2006b). First-In-Man Stent Implantation Clinical Trials & Medical Ethical Dilemmas. Bouve College of Health Sciences, Northeastern University, Boston, MA 02115

 

Read Full Post »


LAUREATES 2017 – – The Dan David Prize is a joint international corporation, endowed by the Dan David Foundation and headquartered at Tel Aviv University

Reporter: Aviva Lev-Ari, PhD, RN

 

THE PRIZE AND ITS SPIRIT

The Dan David Prize is a joint international corporation, endowed by the Dan David Foundation and headquartered at Tel Aviv University.

The Dan David Prize recognizes and encourages innovative and interdisciplinary research that cuts across traditional boundaries and paradigms. It aims to foster universal values of excellence, creativity, justice, democracy and progress and to promote the scientific, technological and humanistic achievements that advance and improve our world.

The Dan David Prize covers three time dimensions – Past, Present and Future – that represent realms of human achievement. Each year the International Board chooses one field within each time dimension. Following a review process by independent Review Commitees comprised of renowned scholars and professionals, the International Board then chooses the laureates for each field.

The Past refers to fields that expand knowledge of former times.
The Present recognizes achievements that shape and enrich society today.
The Future focuses on breakthroughs that hold great promise for improvement of our world.

Three prizes of one million US dollars each are granted annually in the fields chosen for the three time dimensions. The prizes are granted to individuals or institutions with proven, exceptional, distinct excellence in the sciences, arts, humanities, public service and business, that have made and continue to make an outstanding contribution to humanity on the basis of merit, without discrimination of gender, race, religion, nationality, or political affiliation.

The Dan David Pize laureates donate 10% of their prize money to post graduate students in their respective fields, thereby contributing to the community and fostering a new generation of scholars. It is also unique in its outreach efforts to the wider community. Since its inception, the Dan David Prize has embarked upon two exciting innitiatives:

  • The Dan David Prize, in conjunction with the Unit for Science Oriented Youth at Tel Aviv University has initiated the ‘Name Your Hero’ Essay Competition for High School Youth throughout Israel. High school students are encouraged to make a difference and present their choice of candidate and/or suggestions for fields, to the mutual benefit of the Dan David Prize and the students; the fields selected for a given year are influenced by the students’ input and the students’ scholarship and creative writing skills are advanced.
  • A Scholars Forum has been established comprised of Dan David Prize scholarship recipients worldwide doing research in the various fields selected since the inception of the Dan David Prize. This forum serves as a platform for Dan David Prize scholars to discuss research topics, present individual research and exchange ideas and suggestions

For a better understanding of the drive behind the creation of the Prize, press here for Mr. Dan David’s speech at the Inaugurational Ceremony of the Prize, on May 12th 2001.

PAST – ARCHAEOLOGY AND NATURAL SCIENCES

PROF. SVANTE PÄÄBO

PROF. SVANTE  PÄÄBO
Max Planck Institute for Evolutionary Anthropology
GERMANY

PROF. DAVID REICH

PROF. DAVID REICH
Harvard Medical School
USA

PRESENT – LITERATURE

JAMAICA KINCAID

JAMAICA KINCAID
Author
USA

A. B. YEHOSHUA

A. B. YEHOSHUA
Author
ISRAEL

FUTURE – ASTRONOMY

PROF. NEIL GEHRELS (1952-2017)

PROF. NEIL GEHRELS (1952-2017)
NASA Goddard Space Flight Center
USA

PROF. SHRINIVAS KULKARNI

PROF. SHRINIVAS KULKARNI
California Institute of Technology
USA

PROF. ANDRZEJ UDALSKI

PROF. ANDRZEJ  UDALSKI
Astronomical Observatory Warsaw University
POLAND

http://www.dandavidprize.org/laureates/2017?utm_source=newsletter_72&utm_medium=email&utm_campaign=may-is-upon-us-award-ceremony-and-events-dan-david-prize-monthly-news-april-2017

view online »

 Monthly News   Issue # 32  |   April, 2017

The Dan David Prize is an international prize which annually awards three prizes of US$ 1 million each for outstanding scientific, technological, cultural, and social achievements having an impact on our world. Each year fields are chosen within the three Time Dimensions – Past, Present and Future.

 

MAY IS UPON US

AWARD CEREMONY AND EVENTS WITH THE

2017 DAN DAVID PRIZE LAUREATES

 

 

DAN DAVID PRIZE AWARD CEREMONY

Sunday, May 21, 2017, 20:00

The Miriam and Adolfo Smolarz Auditorium

Tel Aviv University

By Invitation Only

Read Full Post »

Older Posts »